Table 23.1 Precursors and their respective moles used for the synthesis of nanodimensional hydroxyapatites

Sample

HA

ZnHA

MgHA

FHA

SiHA

KSiHA

ZnFHA

SrFHA

MgSrHA

MgSrFHA

EuHA

Precursors

used

CNT,

KDP

CNT,

ZNT,

KDP

CNT,

MNT,

KDP

CNT,

KDP,

AF

CNT,

KDP,

TEOS

CNT, KN,

KDP,

TEOS

CNT,

ZNT,

KDP, AF

CNT,

SNT,

KDP, AF

CNT,

MNT,

SNT, KDP

CNT, MNT,

SNT, KDP,

AF

CNT,

ENP,

KDP

Respective

moles

1.0,

0.6

0.98,

0.02,

0.6

0.98,

0.02,

0.6

1.0,

0.6,

0.1

1.0,

0.58,

0.02

0.98, 0.02,

0.58, 0.02

0.98,

0.02, 0.6,

0.1

0.88,

0.12, 0.6,

0.1

0.86, 0.02,

0.12, 0.6

0.86, 0.02,

0.12, 0.6, 0.1

0.98,

0.02,

0.6

23

Unleashing Potential of Bone Mimicking Nanodimensional Hydroxyapatites and. . .

427